Destructive corIleal disease (corneal melting or keratolysis) is a rare but potentially serious compli cation of auto-immune diseases such as rheumatoid arthritis.1 Destruction of corneal tissue takes many forms -from a gradual reduction in stromal thickness of the peripheral cornea (contact lens cornea) to a rapidly progressive peripheral corneal gutter or complete dissolution of corneal tissue?,3 Except in the rare cases of corneal melting associated with severe epithelial changes of Sjogren's syndrome, these changes occur only in the vasculitic phase of rheumatoid arthritis and are always accompanied by post-capillary vascular occlusive changes adjacent to the advancing edge of the peripheral gutter. 4 Histologically the reduction in the flow of these vessels is caused by high endothelium and is associated with an outpouring of inflammatory cells from the vessels. This sometimes leads to scleral inflammation, sometimes to corneal infiltration and destruction and sometimes to both.s If the cornea is involved, then changes can sometimes occur remote from the site of any inflammatory cell infiltrate. The process can usually be reversed by intensive systemic immunosuppression, but occasionally the tissue destruction continues in spite of this, or the process has progressed so far that corneal transplantation is necessary.6-9 These transplants are at high risk both of recurrence of the original disease and from transplantation rejection, as they are either large or implanted into a vascularised cornea. 9 Corneal destruction results from the loss of extracellular matrix, the majority of which is fibrillar collagen type I, and this is associated with an excess of collagen degrading activity.1O-12 The exact patho genesis is unknown, although an immunological process is implicated, driving the process of extra cellular matrix degradation. The matrix metallopro teinases (MMPs) are a family of related enzymes with different substrate specificities, which together are capable of degrading all the components of the extracellular matrixp, 14 Collagenase has long been associated with corneal destruction after injury and alkali-induced burns.10-12 Since many of these early studies, however, it has been shown that there are three collagenolytic MMP enzymes with activity against fibrillar collagenp,14 Interstitial collagenase (MMP-l) is produced by a wide variety of connective tissue cells including fibroblasts and macrophages.
Eye (1995) 9, 703-718 © 1995 Royal College of Ophthalmologists Neutrophils (PMN) produce a different enzyme with a similar activity known as neutrophil collagenase (MMP-8). More recently a third collagenase (MMP-13) has been identified, although little is known about its role in normal and pathological tissues. ls MMPs are first secreted from the cell as an inactive pro-enzyme. Activation in vivo is thought to occur by proteolytic cleavage, mediated by an enzyme cascade probably involving plasmin and/or other MMPs such as stromelysinp, 16 Once activated, control of the enzyme activity is dependent on the local concentration of tissue inhibitors of metallo proteinases (TIMPs) and other non-specific protein ase inhibitors such as armacroglobulin, both of which are found in normal corneas.n,18 Three closely related TIMPs have now been described, the best known of which is TIMP-1, a 28 kDa glycosylated protein containing six disulphide bonds which binds tightly but non-covalently to active metalloprotein ases to form an inactive enzyme-inhibitor complex. 19 In this investigation we used well-characterised antibodies to investigate the expression of interstitial collagenase (MMP-1) and its inhibitor (TIMP-1) in rheumatoid corneas, to determine their role in destructive corneal disease.
PATIENTS AND METHODS

Patients
Eight specimens of corneas were obtained from 5 patients with seropositive rheumatoid arthritis who presented with sterile corneal ulceration during a 2-year period from January 1993 to April 1995. Seven of these specimens were graft tissues which had failed following recurrence of the host disease; the remaining specimen was host tissue obtained at the first grafting operation. Normal corneal buttons (n = 3) were obtained from non-ulcerated eyes as controls: two specimens from cadaver eyes taken but not used for organ donation and one from a child following traumatic injury and corneal scarring.
Immunohistochemistry
Corneal discs were placed in Hank's balanced salts solution immediately after removal and processed for immunohistochemistry less than 1 hour after surgery. Specimens were fixed in ice-cold 4 % paraformalde hyde for 4 hours, equilibrated in 30% sucrose and embedded in TissueTek (Miles, USA). Antigens were detected on frozen sections of 7-10 j.Lm, using the peroxidase-antiperoxidase (PAP) technique combined with a metal-enhanced 3,3' -diaminobenza midine (DAB) substrate (Pierce, USA). In pilot experiments, peroxidase staining was superior to immunofluorescence due to the high background fluorescence associated with many of the corneas. Endogenous peroxidase activity was suppressed by pre-incubating sections for 20 minutes with a G. P. RILEY ET AL.
commercially available peroxidase suppressor (Pierce, USA). Some sections were pre-treated with 1000 U/ml bovine testicular hyaluronidase (Calbio chern) for 1 hour at 37°C, to remove glycosamino glycans and expose hidden epitopes, although this procedure was found to reduce the intensity of matrix staining for collagenase. All subsequent immunolocalisation was conducted without enzy matic pre-treatment. Near-adjacent sections were stained with haematoxylin and eosin. Microscopy was performed on a Nikon Microphot-SA fluores cence photomicroscope and representative fields were photographed using Kodak EKT AR 25 professional film and a x20 objective lens.
Antibodies to MMP-I and TIMP-l The polyclonal and monoclonal antibodies to collagenase and TIMP used in this study have previously been exhaustively characterised, both in our laboratory and elsewhere, zo-23 Briefly, polycJonal antibodies specific to MMP-1 and TIMP-1 were prepared in rabbits, purified by protein A affinity chromatography and mono-specificity tested by Ouchterlony analysis, rocket immunoelectrophor esis and immunoblotting. There was no cross reactivity of the anti-collagenase antibody with neutrophil collagenase (MMP-8) or other MMPs. Polyclonal antibodies were diluted in phosphate buffered saline (PBS) containing 0.1 % bovine serum albumin (BSA) to a final concentration of 20 j.Lg/ml and 80 j.Lg/ml for anti-TIMP-l and anti-collagenase respectively. Pre-immune rabbit immunoglobulins were used at the same concentration for negative controls. Two hybrid om as (RRU-CL1 and RRU CL2) secreting monoclonal antibodies to human interstitial collagenase were produced as described elsewhere 2o , 22 and used on tissue sections at a final concentration of 20 j.Lg/ml. Mouse immunoglobulins (Dako, UK) were used as negative controls.
Antibodies to Cell-Specific Antigens
Monoclonal antibodies specific for helper T cells (CD4), cytotoxic T cells (CD8), monocytes/macro phages (CD68), antigen-presenting cells (HLA-DR) and cells of neuro-ectodermal origin (SlOO) were obtained from Dako (UK) and used as recom mended by the manufacturer. Frozen sections of inflamed human tonsil and purified mouse immuno globulins (Dako, UK) were used for positive and negative controls respectively.
RESULTS
Normal Corneas
Non-ulcerating corneas were examined to determine the normal levels of expression of collagenase and: TIMP. A representative specimen is shown in Fig. 1 . ' There was no detectable collagenase in the stroIDlt 
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of normal corneas, although there was weak expression in the epithelial cell layer. In one specimen we did find a focus of cells expressing collagenase, but this was associated with previous trauma and scarring in the cornea (not shown). In contrast to collagenase, the tissue inhibitor of metalloproteinases (TIMP-l) was abundant and evenly distributed throughout the normal stromal matrix, potentially acting as a reservoir of inhibitory activity. TIMP-l was also abundant in the epithelial layer and the underlying basement membrane.
Collagenase and TIMP-l in Rheumatoid Corneal Disease
The immunohistochemical analysis of the distribu tion of collagenase and TIMP-l for all the corneas is summarised in Table I . Interstitial collagenase was immunolocalised to the stroma in all 8 corneas from rheumatoid patients with destructive corneal disease. The pattern of staining obtained was essentially similar with all Table II . Clinical history of patient 1 three antibodies (one polyclonal and two monoclo nals) to collagenase, with staining localised both to cells and matrix within the corneal stroma. There were, though, considerable differences in the inten sity and distribution of collagenase staining between the different specimens as detailed below. In all corneas, however, collagenase staining was closely associated with regions of cellular proliferation and/ or infiltration of the stroma, and the intensity was greatest in the more cellular regions.
TIMP-l was also detected in the rheumatoid corneal stroma in 7 of 8 corneas, although of weak to moderate intensity and much less intense than in normal cornea. The intensity of staining was also variable, both within different regions of the stroma 
cells (CD4). (B) Cytotoxic T cells (CDS). (C) Monocyteslmacrophages (CD6S). (D) Antigen-presenting cells (HLA-DR). (£) Neuro-ectoderm (epithelial) derived cells (SIOO). (F) Negative control (mouse /gG).
Macrophages were prominent in the cell infiltrate (CD6S+), and many cells (corneal fibrocytes and macrophages) distributed throughout the stroma were activated antigen-presenting cells (HLA-DR+). A significant proportion of cells were derived from the epithelium or limbus (SI 00+), but relatively few cells were expressing T cell markers (CD4 and CDS). Scale bars represent 50 f.lm. and between different specimens (see below). Generally, slightly more intense staining was asso ciated with regions infiltrated by inflammatory cells, whereas adjacent and relatively acellular regions of stroma were weakly stained or negative for TIMP.
INDIVIDUAL CASE REPORTS
Patient 1
This 70-year-old man had developed seropositive rheumatoid arthritis at the age of 23 years, when he presented with mono-arthritis of one knee and subsequent involvement of many other joints. He was treated with non-steroidal anti-inflammatory drugs, corticosteroids and gold and the joint disease became inactive at the age of 50 years. He was not severely handicapped thereafter and required only analgesic preparations. He did, however, develop extra-articular manifestations of sub-cutaneous nodules; moderate keratoconjunctivitis sicca and xerostomia. He retained some tear secretion (Schirmer's test: 5 mm right eye, 3 mm left eye).
In October 1988 he developed a spontaneous non infectious corneal ulceration and rapid perforation of the right eye. There was no associated change in his rheumatoid arthritis. The perforation healed with a conjunctival flap and a further perforation 4 weeks later was treated with a bandage lens, and healed. In June 1989 the left eye developed a similar problem and perforated. This was treated with a conjunctival flap but the melting process continued and he had to be treated with corneal transplantation and immu nosuppression. Unfortunately the disease recurred on many occasions in the grafted tissue, requiring repeated corneal transplants (Table II) . Subse quently he was treated with CAMPATH-1H after the tenth graft and this has since remained clear. 24 Immunohistochemistry was performed on the corneal button obtained from the eighth graft to fail, following a recurrence of rheumatoid disease. Collagenase was localised to one half of the corneal disc, extending from the epithelial surface across half the thickness of the cornea and restricted to a region of corneal fibrocyte proliferation and an inflamma tory mononuclear cell infiltrate (Fig. 2) . There was a gradient of decreasing intensity of collagenase staining, extending from the epithelial surface towards the centre of the tissue, which correlated with the change in cell density. Collage nase was located both within the cytoplasm of the stromal cells and in the immediate pericellular matrix. The cells staining positive were generally of rounded morphology (Fig. 2e) . Staining was also found associated with the surrounding stromal matrix and could be reduced by hyaluronidase pre-treat ment of the section, which suggests that the collagenase was associated with some labile (pre sumably glycosaminoglycan) component of the stromal matrix. Collagenase was notably absent from adjacent areas of corneal stroma with a more normal cellularity and from acellular regions of the tissue. Although the epithelium and basement membrane were not always present or preserved on these frozen sections, collagenase was also detected in some regions of epithelium, particularly overlying or adjacent to the inflammatory cell infiltrate.
The composition of the cell infiltrate was char acterised by a battery of monoclonal antibodies to cell surface antigens. The cell infiltrate consisted mainly of macrophages (CD68+) with a small number of helper T cells (CD4+) and cytotoxic T cells (CD8+) and was characteristic of rheumatoid lesions (Fig. 3) ?,25 Many cells throughout the stroma were activated antigen-presenting cells (HLA-DR+) and a small proportion of cells were expressing the Table III . Clinical history of patient 4 S100 antigen, a marker of cells of neuro-ectodermal (epithelial) origin.
Patient 2
This 66-year-old woman developed seropositive rheumatoid arthritis at the age of 36 years. At some time or another since then all the joints have been involved, but the only severe changes were in the hands. For the previous 2 years the pain and joint activity had diminished but still required treatment with 5 mg prednisolone daily and indomethacin 75 mg daily. On 2 August 1994 she perforated the left cornea. The eye had not previously been uncomfor table and there was no pain. The vision was limited to counting fingers but was said to be moderately good before the eye perforated. The medication was changed to 10 mg prednisolone daily and 75 mg methotrexate weekly. She was immunosuppressed on this medication. The total white cell count was 9.9 X 10 9/1 and the lymphocyte count was 0.8 X 109/1. The ESR was 60 mm in 1 hour, but this fell when she was given 60 mg systemic prednisolone. Initially the eye responded to tissue glue under a bandage contact lens. The glue separated without sealing the perforation and a further attempt failed. Corneal transplantation was therefore undertaken. The vision was poor (bare hand movements) before the operation but fell to no perception of light after wards. CT scanning showed atrophy of the optic nerve and it was considered that the poor vision and other ocular changes were due to a severe rheuma toid vasculitis.
Immunohistochemistry was performed on the ulcerating host tissue obtained from this patient. The intensity of staining for collagenase was much reduced compared with patient 1 and the majority of the matrix was negative. Not surprisingly, the absence of staining correlated with the relatively acellular and necrotic appearance of the corneal stroma and, unlike patient 1, there was no substantial influx of mononuclear inflammatory cells (Fig. 4) . The small amount of collagenase that was present in the stroma was associated with a small number of cells close to the epithelial surface of the tissue (not shown). TIMP-1 was only very weakly expressed or absent from the whole corneal stroma, although there was more intense staining at the basement membrane/epithelial surface which was thought not to be an edge effect or artefact of staining (Fig. 4D) .
Patient 3
This 76-year-old man recently developed seroposi tive rheumatoid arthritis involving hands, elbows and knee joints. This responded to treatment with gold and non-steroidal anti-inflammatory drugs. However, after 2 years he developed a red painful eye. Examination showed an extensive painful corneal gutter, which rapidly progressed to perforation requiring penetrating keratoplasty. The specimen was obtained from host tissue at the first grafting operation.
The intensity and distribution of collagenase staining in the corneal button were essentially similar to that observed for patient 1, with a strong association of collagenase with an extensive inflam matory cell infiltrate, extending from the epithelial surface. Collagenase was also associated with the epithelium where present on the section, although the full thickness of epithelial cells was lost from the region in close proximity to the inflammatory cell infiltrate.
Patient 4
This 50-year-old woman developed seropositive rheumatoid arthritis as an acute illness at the age of 33 years. There was rapid progression of her disability, in spite of intensive treatment. She required surgical treatment for her joint disease (23 operations in all) and by this means maintained her mobility and remained relatively pain free. A paternal aunt and a brother also suffer from rheumatoid arthritis. By 1991 the arthritis had become relatively inactive but she then developed an infected knee joint and a severe gram-negative septicaemia with renal failure, congestive heart failure and temporary antro-vascular accident. The recovery was prolonged but complete. In 1992 she developed a non-infectious corneal ulcer in the left eye. This was treated by a penetrating keratoplasty. Three months later she developed a herpetic keratitis which resulted in perforation of the cornea. Since then she has had multiple corneal transplants due to recurrence of the original disease in the graft. The final 13 mm keratoplasty has remained clear to date (Table III) .
Two specimens from the fourth and sixth grafts respectively were taken for immunohistochemical analysis. In the first specimen (fourth graft), collagenase was moderately abundant in the stroma and associated with a mononuclear cell infiltrate much as described in patients 1 and 3 (not shown). In the second specimen (sixth graft), collagenase was absent from much of the corneal stroma, the majority of which had a relatively normal histology, although there were some regions of fibrocyte proliferation and epithelial thinning (Fig. 5) .
The relative absence of collagenase was consistent with the immunosuppressed (quiescent) nature of the host disease which was noted at the time of keratoplasty. However, a small focus of collagenase staining was found, but restricted to one edge of the corneal disc, to the pericellular domain of cells infiltrating from the corneal-scleral junction or limbus (Fig. 5G) . In both specimens, TIMP-1 staining was of weak to moderate intensity, and marginally increased in the more cellular regions of the stroma.
Patient 5
This 64-year-old man had had severe rheumatoid arthritis since the age of 24 years. All his joints became affected and he had both hips and knees replaced. The joint disease became quiescent in the late 1980s but he had increasing chest pain on exercise and showed evidence of diffuse arterial disease. He had a strong family history of rheuma toid arthritis, his mother and sister being severely affected.
In July 1992 he developed an irritation in his left eye and was found to have a corneal gutter which progressed in spite of treatment, and perforated. This was treated initially by conjunctival excision but this did not improve the condition. He was found to have an active rheumatoid vasculitis so he was treated with methylprednisolone and cyclophosphamide and the gutter healed. One month later, however, he developed a staphylococcal endophthalmitis; this responded to antibiotics but the cornea became extremely thin. Grafting was delayed because he had developed chest pain at rest. However, by November 1992 he was able to have an eccentric patch graft, cataract extraction and intra-ocular lens implanta tion. Histology of the cornea, iris and ciliary body removed at the time showed extensive infarction of this tissue.
This and subsequent grafts survived for short periods (6 months and 2 months respectively) and then he had a recurrence of the corneal ulceration.
The graft was repeated and the final graft remained cloudy but viable until his death 1 year later. Latterly he developed a retinal detachment but this was not treated.
In the first graft specimen to be obtained from this patient, there was relatively little mononuclear cell infiltrate, although there was an increase in corneal fibrocytes, with some small bundles of cells having the appearance of new blood vessels. Collagenase was mainly associated with corneal fibrocytes, many of which were aligned parallel and close to the epithelial surface (Fig. 6) .
In the subsequent two corneal specimens, collagen ase was also relatively abundant in the stromal matrix, but associated particularly with clumps of rounded cells in regions of an extensive inflammatory cell infiltrate, similar to that described previously (not shown). In all specimens, TIMP-l staining was of weak to moderate intensity, with a slightly greater intensity in association with the cellular infiltrate or fibrocytes, particularly close to the epithelial surface as shown in Fig. 6G .
Characterisation of the Inflammatory Cell Infiltrate
Although there were some differences in the quantity of cells between the different specimens, the composition of the mononuclear cell infiltrate (where present) was generally similar in each of the rheumatoid corneas and characteristic of rheumatoid lesions (Fig. 3) .3,25-27 There were relatively few T cells and the most abundant cells were macrophages. Many cells both within the infiltrate and throughout the corneal stroma were expressing the HLA-DR antigen, indicating activated antigen-presenting cells. None of the cell markers was present in histologically normal corneas, with the exception of a few activated macrophages (HLA-DR +ve, CD68 +ve) in the region of scarring and collagenase expression found in one of the normal specimens (not shown).
DISCUSSION
Sterile corneal ulceration is a rare but potentially devastating complication of rheumatoid arthritis.1 The pathogenesis is unknown, but is presumed to be an immune-mediated process, associated with an inflammatory response at the corneal-scleral junc tion with mononuclear cells infiltrating the cornea from the limbus?8 However, as yet there is no unifying hypothesis to explain the occurrence of central and paracentral corneal ulcers, which often present without ocular inflammation, although pre vious epithelial injury and aqueous tear deficiency have been implicated? This is the first report of the possible role of the matrix metalloproteinase collagenase (MMP-l) and its inhibitor (TIMP-l) in the pathogenesis of corneal destruction in rheumatoid arthritis. Interstitial collagenase was abundantly expressed by cells in the corneal stroma in 6 of 8 ulcerating rheumatoid corneas, but was not found in histologically normal corneal stroma. In the remaining 2 rheumatoid specimens, collagenase was weakly expressed in small foci of infiltrating cells, but absent from most of the stroma, probably as a result of tissue necrosis in one case (patient 2) and quiescent disease in the other (patient 4, specimen 2). Although we did observe some collagenase in 'normal' corneal epithelium, this is probably a result of previous traumatic insult in one case, and the culturing of the cornea in the other cases -a procedure which is known to induce collagenase expression in the cornea. 12 Interstitial collagenase (MMP-l) can be produced by a variety of tissue cells including fibroblasts and macrophages and is one of the few enzymes capable of cleaving fibrillar collagens within the collagen triple-helix.13,14 Thus the control of collagenase activity is thought to be the rate-limiting process in the turnover and remodelling of connective tissues, in both normal and pathological situations. Although previous studies have reported metalloproteinase and specifically collagenase activity produced by corneal fibrocytes in ulcerating and remodelling corneas,l0-12,28,2 9 to our knowledge this is the first study to examine the distribution of both MMP-l and its specific inhibitor (TIMP-l) in patients with well characterised rheumatoid disease. Our observations are consistent with the hypothesis that MMP-l is one of the major enzymes involved in the degradation of the corneal matrix seen in rheumatoid corneal ulceration.
Collagenase and other metalloproteinases are synthesised and secreted as inactive pro-enzymes, which are activated in the matrix by proteolytic cleavage.13,14,16 Once activated, levels of collagenase activity are dependent on the local concentration of the TIMPs, which rapidly form a tightly bound inactive complex with active metalloproteinasesp, 1 9 In this study we have shown that TIMP-l is abundantly expressed throughout the normal cor neal stroma, presumably bound to some component of the stromal matrix. The presence of TIMP in the normal stroma is likely to have a physiological role maintaining corneal integrity, as it has been shown that both synthetic metalloproteinase inhibitors and recombinant TIMP-l can prevent corneal ulceration in animal models?O,31 TIMP-l and TIMP-2 have previously been shown to be produced by normal corneal fibrocytes,32,33 and together with non-specific protease inhibitors produced in the cornea such as Ct 2 -macroglobulin,18 would provide a reservoir of inhibitory activity against metalloproteinase activity and act to maintain tissue homeostatis.
In this study we found that TIMP-l was also expressed in the majority (7/8) of rheumatoid corneas, but the intensity of staining was much weaker than in normal corneas, in particular in the hypocellular and acellular regions of the stroma. Of course the methods used in this study do not provide quantitative data on the relative levels of collagenase and TIMP, but our observations are consistent with the hypothesis that collagen degradation is occurring where levels of active collagenase are in excess of levels of TIMP. We also observed that TIMP was relatively more abundant in the hypercellular regions of stroma -areas which also contained cells expressing collagenase. We could not determine in this study whether collagenase and TIMP were being expressed by the same or different cells within the infiltrated tissue, although coordinate expression of enzyme and inhibitor has been reported in fibroblast cell cultures?4 This presumably represents a homeo static mechanism to control excessive local tissue destruction. Our observations would suggest that in normal cornea, levels of TIMP and other proteinase inhibitors are sufficient to inhibit any metalloprotei nase activity. In destructive corneal disease, reduced local levels of TIMP-l production may be permissive of excessive matrix degradation by collagenase and other· metalloproteinases. However, more work needs to be done to investigate the production of other matrix metalloproteinases in diseased cornea, in addition to metalloproteinase inhibitors such as TIMP-2, TIMP-3 and u 2 -macroglobulin. The cellular source of the collagenase and TIMP-l, and the precise nature of the antigenic stimulus and/ or inflammatory mediators driving the process of corneal destruction, remain the source of some conjecture. Matrix metalloproteinases can be pro duced by a variety of different cell types in the eye. Stromal fibroblasts can express interstitial collagen ase (MMP-l) and stromelysin (MMP_3),2 9 and both epithelial and stromal cells produce collagenase in addition to the 72 kDa and 92 kDa gelatinases (MMP-2 and MMP-9 respectively)?5 In this study we found that collagenase (MMP-l) was strongly associated with an inflammatory mononuclear cell infiltrate, similar to that described previously in ulcerating rheumatoid corneas,3,25 in scleritis26 and in rheumatoid joint synovium?6 The high density of activated macrophages suggests that these cells might be the source of the enzyme. However, the corneal fibroblasts might also be synthesising collagenase in response to pro-inflammatory cytokines (such as interleukin-l), which are produced by activated macrophages and have been shown to up-regUlate collagenase expression in corneal stromal cells ?7 Fibrocytes and macrophages throughout the corneal stroma were expressing HLA-DR antigens, demonstrating activation in response to either direct antigenic stimulation and/or the production of local G. P. RILEY ET AL. inflammatory mediators. Although T cells might be the source of activating cytokines such as interferon ,,{, the low number of T cells present in the ulcerating corneas might suggest a lesser role for these cells and their products. Many infiltrating cells were also expressing the SIOO antigen, a marker of cells of neuro-ectodermal origin, such as dendritic Langer hans cells derived from the epithelium and/or limbus. These phagocytic cells are presumably migrating into the tissue in response to mitogenic stimuli produced by cells in the stroma. Candidate signalling molecules include pro-inflammatory cytokines such as inter leukin-l and tumour necrosis factor alpha, both of which have been associated with ocular inflammation as reviewed by Kijlstra.27 Briefly, corneal cells from the stroma and epithelium both produce and respond to interleukin-l, which can stimulate the production of prostaglandins and cytokines such as interleukin-6, monocyte chemotactic protein (MCP) and interleu kin-8, which in turn attract and activate macro phages and leucocytes thus amplifying the inflammatory response. This might occur as a result of damage to the epithelium and/or some component of the stromal matrix, perhaps revealing hidden epitopes which can stimulate the development of an auto immune response in susceptible individuals, although the relative contribution of humoral and cell mediated immunity to this process is unknown. However, the macrophage and other antigen-pre senting cells are likely to play a major role in both initiating and maintaining the chronic inflammatory response and corneal destruction, as described in other rheumatoid lesions? 8 Finally a number of studies have demonstrated the importance of interactions between epithelial and stromal cells, which are a requirement for the induction of collagenase in corneal fibrocytes in culture. 1O,32 In this study we observed that the intensity of collagenase staining was generally more intense closer to the epithelial surface, consistent with the progression of ulceration from the epithe lium to the stroma. One explanation for this distribution might be the production of some signalling molecule(s) derived from the epithelium such as platelet activating factor (PAF) , a lipid derived inflammatory mediator which is generated in the cornea in response to injury and inflammation and stimulates collagenase expression by corneal epithelial cells? 9 Oth�r studies have reported immune complexes deposited in the epithelial cell layer in ulcerating rheumatoid corneas, 3,25 although the pathological significance of these observations is unknown. We and others have previously noted the importance of maintaining the integrity of the epithelial layer in the success of corneal grafts?, 9 ,25 Taken together, these observations would suggest a link between cell-mediated events occurring at or close to the epithelial surface of the cornea, involving macrophage infiltration from the limbus, collagenase expression and activation by corneal fibrocytes within the stroma, a reduction in TIMP expression and ultimately corneal destruction.
